Research on antidepressant drugs distorted by pharmaceutical industry

‘According to a recent study, authors of articles conducting meta-analyses of antidepressant drugs in clinical trials with links to industry were 22 times less likely to report negative statements about a drug than authors with no industry affiliation.

The findings were published in September in the Journal of Clinical Epidemiology. The researchers collected 185 meta-analyses of antidepressant trials listed in MEDLINE between 2007 and 2014. They looked at author affiliations and conflict of interest statements and found that 54 (29 percent) of the studies had authors who were employees of the drug maker, while 145 (78 percent) of the studies had some industry link (through funding, employment or other conflict of interest).’

Read more: Research on antidepressant drugs distorted by pharmaceutical industry

The post Research on antidepressant drugs distorted by pharmaceutical industry appeared first on David Icke.